Cargando…
Significance of KRAS/PAK1/Crk pathway in non-small cell lung cancer oncogenesis
BACKGROUND: Key effector(s) of mutated KRAS in lung cancer progression and metastasis are unknown. Here we investigated the role of PAK1/Crk axis in transduction of the oncogenic KRAS signal in non-small cell lung cancer (NSCLC). METHODS: We used NSCLC clinical specimens to examine the correlation a...
Autores principales: | Mortazavi, Fariborz, Lu, Jie, Phan, Ryan, Lewis, Michael, Trinidad, Kenny, Aljilani, Amir, Pezeshkpour, Gholamhossein, Tamanoi, Fuyuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477307/ https://www.ncbi.nlm.nih.gov/pubmed/25956913 http://dx.doi.org/10.1186/s12885-015-1360-4 |
Ejemplares similares
-
PAK1 Kinase Promotes Cell Motility and Invasiveness through CRK-II Serine Phosphorylation in Non-Small Cell Lung Cancer Cells
por: Rettig, Matthew, et al.
Publicado: (2012) -
PAK Signaling in Oncogenesis
por: Molli, Poonam R., et al.
Publicado: (2009) -
Crk and CrkL adaptor proteins: networks for physiological and pathological signaling
por: Birge, Raymond B, et al.
Publicado: (2009) -
c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells
por: Mortazavi, Fariborz, et al.
Publicado: (2011) -
Crk and CrkL as Therapeutic Targets for Cancer Treatment
por: Park, Taeju
Publicado: (2021)